Clinical Trials Sponsored by Domain Therapeutics SA
Total 28 results
-
Domain Therapeutics SARecruitingSolid Tumor, AdultFrance, Belgium
-
Ryvu Therapeutics SARecruitingAdvanced Solid TumorSpain, Poland
-
Cerenis Therapeutics, SACompleted
-
SeneXta Therapeutics SACompleted
-
Ryvu Therapeutics SANot yet recruitingMyelofibrosisItaly, Poland
-
Ryvu Therapeutics SARecruitingAcute Myeloid LeukemiaItaly, Poland
-
Ryvu Therapeutics SAActive, not recruitingAcute Myeloid Leukemia | High-risk Myelodysplastic SyndromeUnited States, Poland
-
Cerenis Therapeutics, SATerminatedFamilial HypoalphalipoproteinemiaFrance, United States, Belgium, Canada, Israel, Italy, Netherlands
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Cerenis Therapeutics, SACompletedAcute Coronary SyndromeCanada, United States, France, Netherlands
-
Ryvu Therapeutics SARecruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic SyndromePoland
-
Calliditas Therapeutics Suisse SAActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, France, United States, Germany, Italy, Poland, United Kingdom
-
Calliditas Therapeutics Suisse SAActive, not recruitingPrimary Biliary Cholangitis | Liver StiffnessUnited States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
iTeos Belgium SACompleted
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
iTeos Belgium SAGlaxoSmithKline; iTeos TherapeuticsRecruitingMelanoma | Head and Neck Cancer | Lung Cancer | Advanced CancerSpain, Italy, France, United States, United Kingdom, Belgium
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdRecruitingTriple Negative Breast Cancer (TNBC)India
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
iTeos Belgium SABristol-Myers Squibb; GlaxoSmithKline; iTeos TherapeuticsTerminatedMultiple MyelomaUnited States, France, Spain, Belgium
-
Cerenis Therapeutics, SASouth Australian Health and Medical Research InstituteCompletedAcute Coronary SyndromesUnited States, Australia, Netherlands, Hungary
-
Damian Pharma AGUniversity Hospital Inselspital, Berne; Covance; Foundation for Therapeutic Research...Completed
-
University of BirminghamRegeneron Pharmaceuticals; Cancer Research UK; Fight Kids Cancer; ADC Therapeutics...Not yet recruiting
-
Xuanwu Hospital, BeijingH. Lundbeck A/S; Hoffmann-La Roche; Genentech, Inc.; Life Molecular Imaging SA; APRINOIA... and other collaboratorsRecruitingAlzheimer DiseaseChina
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; University of Florence; Medical University... and other collaboratorsNot yet recruitingLow Risk Myelodysplastic SyndromesSpain, Poland, Italy, Germany, France